Indrani Franchini - Feb 1, 2022 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
EVP, CLO & Secretary
Signature
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Indrani Franchini
Stock symbol
ALNY
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
4
Date filed
2/9/2022, 07:59 PM
Previous filing
Feb 9, 2022
Next filing
Feb 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Award $0 +15.5K $0.00 15.5K Feb 1, 2022 Common Stock 15.5K Direct F1, F2
transaction ALNY Stock Option (right to buy) Award $0 +29.2K $0.00 29.2K Feb 1, 2022 Common Stock 29.2K $144.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F2 The restricted stock units vest ratably on each of the first, second and third anniversaries of the Grant Date.
F3 The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.